<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p49" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_49{left:130px;bottom:1195px;letter-spacing:0.21px;}
#t2_49{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_49{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_49{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_49{left:238px;bottom:1061px;letter-spacing:-0.01px;}
#t6_49{left:238px;bottom:1042px;letter-spacing:-0.01px;}
#t7_49{left:238px;bottom:1022px;letter-spacing:-0.01px;}
#t8_49{left:238px;bottom:1003px;letter-spacing:-0.01px;}
#t9_49{left:238px;bottom:983px;letter-spacing:-0.01px;}
#ta_49{left:238px;bottom:964px;letter-spacing:-0.01px;}
#tb_49{left:238px;bottom:944px;letter-spacing:-0.01px;}
#tc_49{left:238px;bottom:925px;letter-spacing:-0.01px;}
#td_49{left:238px;bottom:906px;letter-spacing:-0.01px;}
#te_49{left:238px;bottom:886px;letter-spacing:-0.01px;}
#tf_49{left:238px;bottom:867px;letter-spacing:-0.01px;}
#tg_49{left:238px;bottom:847px;letter-spacing:-0.01px;}
#th_49{left:238px;bottom:828px;letter-spacing:-0.01px;}
#ti_49{left:238px;bottom:696px;letter-spacing:-0.01px;}
#tj_49{left:238px;bottom:677px;letter-spacing:-0.01px;}
#tk_49{left:238px;bottom:657px;letter-spacing:-0.01px;}
#tl_49{left:238px;bottom:623px;letter-spacing:0.11px;}
#tm_49{left:238px;bottom:603px;letter-spacing:0.11px;}
#tn_49{left:238px;bottom:568px;letter-spacing:-0.01px;}
#to_49{left:238px;bottom:549px;letter-spacing:-0.01px;}
#tp_49{left:238px;bottom:529px;letter-spacing:-0.01px;}
#tq_49{left:238px;bottom:495px;letter-spacing:-0.01px;}
#tr_49{left:238px;bottom:475px;letter-spacing:-0.01px;}
#ts_49{left:238px;bottom:456px;letter-spacing:-0.01px;}
#tt_49{left:238px;bottom:436px;letter-spacing:-0.01px;}
#tu_49{left:432px;bottom:436px;letter-spacing:-0.01px;}
#tv_49{left:238px;bottom:363px;letter-spacing:-0.01px;}
#tw_49{left:238px;bottom:343px;letter-spacing:-0.01px;}
#tx_49{left:238px;bottom:324px;letter-spacing:-0.01px;}
#ty_49{left:238px;bottom:304px;letter-spacing:-0.01px;}
#tz_49{left:238px;bottom:285px;letter-spacing:-0.01px;}
#t10_49{left:238px;bottom:266px;letter-spacing:-0.01px;}
#t11_49{left:238px;bottom:246px;letter-spacing:-0.01px;}
#t12_49{left:238px;bottom:227px;letter-spacing:-0.01px;}
#t13_49{left:238px;bottom:207px;letter-spacing:-0.01px;}
#t14_49{left:238px;bottom:188px;letter-spacing:-0.01px;}
#t15_49{left:238px;bottom:168px;letter-spacing:-0.01px;}
#t16_49{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_49{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_49{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_49{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts49" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg49Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg49" style="-webkit-user-select: none;"><object width="908" height="1286" data="49/49.svg" type="image/svg+xml" id="pdf49" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_49" class="t s0_49">6.7 Patient information / education </span><span id="t2_49" class="t s1_49">49 </span>
<span id="t3_49" class="t s2_49">Joint information between patient and family facilitates communication within the </span>
<span id="t4_49" class="t s2_49">partnership and family. This should be communicated to the patient. </span>
<span id="t5_49" class="t s2_49">Since laryngeal carcinoma can affect several functions, such as voice production, swallowing </span>
<span id="t6_49" class="t s2_49">and breathing, the patient must be given a detailed explanation of the possible disorders that </span>
<span id="t7_49" class="t s2_49">can arise after such an operation. This first information session with the patient and their </span>
<span id="t8_49" class="t s2_49">relatives is important so that they can decide on the right therapy for them. However, the </span>
<span id="t9_49" class="t s2_49">patient will often follow the recommendations of the treating doctor, which makes it all the </span>
<span id="ta_49" class="t s2_49">more important to show the consequences of appropriate treatment. Since most patients have </span>
<span id="tb_49" class="t s2_49">no idea about the anatomy of the larynx, the explanations must be clearly explained to the </span>
<span id="tc_49" class="t s2_49">patient with the help of schematic drawings. Many patients also need to be aware of the </span>
<span id="td_49" class="t s2_49">seriousness of the disease; this is particularly true of smaller carcinomas that only lead to </span>
<span id="te_49" class="t s2_49">minor functional impairments such as mild hoarseness. In order to provide the patient with a </span>
<span id="tf_49" class="t s2_49">broad picture of the treatment options, it is necessary to consult not only an ENT surgeon but </span>
<span id="tg_49" class="t s2_49">also a radiotherapist (and, if appropriate, an internal oncologist) who can advise and weigh up </span>
<span id="th_49" class="t s2_49">radiotherapy (or internal therapy) versus surgical therapy. </span>
<span id="ti_49" class="t s2_49">The patient must always be informed about the chances of success. If information is given on </span>
<span id="tj_49" class="t s2_49">the probability of recovery, these should be given as absolute (and not relative) frequencies </span>
<span id="tk_49" class="t s2_49">[138, 139]. </span>
<span id="tl_49" class="t s1_49">Patients should also be informed about the likely risks and consequences of not undergoing </span>
<span id="tm_49" class="t s1_49">treatment. </span>
<span id="tn_49" class="t s2_49">The patient may also be present at the tumor board meetings so that the advantages and </span>
<span id="to_49" class="t s2_49">disadvantages of various treatment options, including the prospects of success, can be </span>
<span id="tp_49" class="t s2_49">discussed in his or her presence. </span>
<span id="tq_49" class="t s2_49">A representative of the Association of Larynxless People should also be included in the patient </span>
<span id="tr_49" class="t s2_49">information session. It is very helpful if the patient can be put in touch with a patient who has </span>
<span id="ts_49" class="t s2_49">undergone a similar therapy. This will help the patient understand the situation after therapy </span>
<span id="tt_49" class="t s2_49">and give them a better idea of </span><span id="tu_49" class="t s2_49">the functional impairments and the rehabilitation options. </span>
<span id="tv_49" class="t s2_49">If the patient has decided to undergo treatment, they must of course be informed about this in </span>
<span id="tw_49" class="t s2_49">detail. The information should be provided by the surgeon himself or by a doctor who has </span>
<span id="tx_49" class="t s2_49">sufficient experience in the field of the proposed therapy. It is particularly important for the </span>
<span id="ty_49" class="t s2_49">patient to be informed about the prognosis regarding voice production, breathing and </span>
<span id="tz_49" class="t s2_49">swallowing as well as visible - and thus potentially stigmatizing - changes to the face and neck </span>
<span id="t10_49" class="t s2_49">after the therapeutic measure [140]. It is also important whether a permanent tracheostomy or </span>
<span id="t11_49" class="t s2_49">a temporary tracheotomy is performed, as well as whether a tracheostomy tube must be worn </span>
<span id="t12_49" class="t s2_49">and, if so, what type (blocked or unblocked) it must be. In the case of partial laryngectomy, in </span>
<span id="t13_49" class="t s2_49">addition to the possible impairment of voice production, aspiration is also a significant problem </span>
<span id="t14_49" class="t s2_49">that the patient must be informed about. "The person who has to consent to the medical </span>
<span id="t15_49" class="t s2_49">procedure - usually the patient himself - must be informed." To inform the patient, </span>
<span id="t16_49" class="t s0_49">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
